Keywords
Stroke, Pakshaghata, Panchkarama, Niruha Vasti, Dashmoola, Adjuvant, Physiotherapy, MRP, FES
This article is included in the Datta Meghe Institute of Higher Education and Research collection.
Stroke is ischemia and neurological dysfunction caused by acute brain circulation loss. It causes acute localized neurological abnormalities such as weakness, sensory deficit, or language issues that require long-term treatment. These deficiencies harm the patient and their family psychologically, socially, and economically. Thus, combination treatment can rapidly rehabilitate such patients. Detoxification methods like Ayurvedic medicated enema help stroke pathophysiology. Physical modalities in physiotherapy have been shown to facilitate normal movement and function on the stroke patient’s affected side, increasing independence with everyday duties. A stroke patient may benefit from Dashmoola Niruha Vasti, Function Electrical Stimulation (FES), and Motor Relearning Programme (MRP).
This study compares the adjuvant role of Dashmoola Vasti with MRP and FES in stroke recovery. The main goals of this study are to assess and compare the adjuvant role of Dashmoola Vasti with standard control over sensorimotor function of lower extremities; static & dynamic balance in stroke patients; gait parameters; resistance experienced during passive range of motion; quality of life of patients; Barthel Index; Modified Ashworth Scale; and Fuglmeyer assessment, Single Limb Stance Test, Functional Reach Test.
A total of 40 patients will be enrolled and divided randomly into two equal groups. In Group A (control), standard treatment (modern + physiotherapy) will be prescribed for one month. In Group B (interventional group), Dashmoola Vasti will be added to the afore-said standard treatment for one month.
Improvement in Fuglmeyer assessment, Single Limb Stance Test, Functional reach test, quality of life of patients, Barthel Index, Modified Ashworth scale and National Institute of Health (NIH) stroke-scale-score, will be observed and recorded.
Results and conclusions will be derived according to the data collected in case record form and assessment sheets filled at baseline and follow-up visits.
CTRI/2021/10/037445 dated 21.10.2021.
Stroke, Pakshaghata, Panchkarama, Niruha Vasti, Dashmoola, Adjuvant, Physiotherapy, MRP, FES
In clinical practice, stroke has been very notorious for impeding the continuity of life and day-to-day activities. It is the most common example of such a crippling disorder. On extensive review of contemporary literature, it is observed that, despite massive worldwide efforts in this science to rectify early results in reducing the risk of death or disability, it is disappointing.1 Partial recovery is obtained after a particularly long time. Moreover, it is observed that there are certain limitations, contra-indications, or side effects of currently established treatment modalities for stroke.2
Considering the complicated and critical nature of the disease, i.e., stroke, it becomes imperative to search for safe, promising and effective treatment modalities in alternative sciences for early rehabilitation purposes for stroke. Though most of the studies suggest that the individual use of Panchakarma therapy, especially external oleation (Bahya Snehana), sudation therapy (Swedana) along with medicated enema (Vasti) and conventional physiotherapy, i.e., Motor Relearning Programme (MRP), and the combination of electrical modality with Functional Electrical Stimulation (FES) shows promising results in the rehabilitation of patients with stroke.
However, no study has been carried out to assess their combined effects on the therapeutic outcome of the rehabilitation of such patients. Moreover, the research is also required to determine the MRP and FES combined effect of supporting stroke patients for improving knee extension and gait parameters. Therefore, this study is proposed to generate clinical evidence showing excellent post-stroke recovery within a short time in restoring gross and fine movements to the maximum extent in a quicker manner.
The study’s goal is to analyze and compare the adjuvant role of Dashmoola Vasti with standard treatment in stroke rehabilitation. In addition, the efficacy of physiotherapy (MRP and FES) in the rehabilitation of stroke patients will be assessed. The study’s goal is to assess and compare the adjuvant role of Dashmoola Vasti with standard control over sensorimotor function of lower extremities in stroke patients using the Fugl-Meyer assessment, as well as to assess and compare the adjuvant role of Dashmoola Vasti with standard control over static and dynamic balance in stroke patients using the Single Limb Stance Test and Functional Reach Test, respectively. The secondary goal is to evaluate and compare the adjuvant role of Dashmoola Vasti with standard control over gait parameters (distance and time parameters), the Barthel Index, resistance experienced during passive range of motion based on the modified Ashworth scale, and the National Institute of Health (NIH) stroke-scale-score in stroke patients.
IEC clearance is taken from the Institutional Ethical Committee, Datta Meghe Institute of Higher Education and Research (DMIHER), Wardha. IEC certificate obtained: Ref No. DMIHER (DU)/IEC/2021/279 dated 15.04.2021. The project has been registered with Clinical Trials Registry India (CTRI) (registration number CTRI/2021/10/037445) dated 21.10.2021).
Written informed consent will be taken from the patient before starting the study. During the study, the confidentiality of each patient will be maintained.
It is an interventional study, it is a superiority clinical trial, i.e., randomized reference standard control open-labeled two-arm comparative clinical trial.
Due to practical considerations such as cost, patient inconvenience, judgments not to proceed with an investigation or a lengthy study duration, the number of participants in the study is restricted. So for the phase-I trial, 20 sample size is considered for each group.3
Daily visit to the stroke inpatient ward is planned at Acharya Vinoba Bhave Rural Hospital, and if the patient is willing to enroll in the said study can be recruited for the study after written informed consent. Patients will be added one at a time until the target sample size is reached.
Locus of the study: out patient department and inpatient department of Panchakarma & Kayachikitsa department, Mahatma Gandhi Ayurveda College Hospital and Research Centre (MGACH&RC), Salod (Hirapur) Wardha, Maharashtra. & Department of Neuro physiotherapy, Ravi Nair Physiotherapy College, Sawangi, Wardha Maharashtra, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra.
Study setting: The study will be conducted in Panchakarma OPD & IPD, Mahatma Gandhi Ayurveda College Hospital and Research Centre (MGACH&RC), Salod (Hirapur) Wardha, Maharashtra.
Patients will be recruited after approval from Clinical Trials Registry- India (CTRI), and the exposure period for treatment will be one month. The follow-up will be conducted on the 60th and 90th day of treatment.
Criteria for discontinuing or modifying: if patients are willing to quit in between they will be allowed to quit and will be replaced; if the patient develops an acute illness during the trial, which may hamper the study and withdrawn patients will be replaced.
Diagnosed cases of stroke will be enrolled in the study with the computerized randomization method.
The inclusion criteria for the study are the patients with the first stroke diagnosed with CT/MRI (thrombolytic stroke only) without other neurological deficits but < six months of onset, patients diagnosed as stroke with ICD code 2020 ICD-10-CM Diagnosis Code I69.351 patients between 45 to 60 years of age irrespective of gender/occupation and socio-economic status. Patients with controlled hypertension and Noninsulin dependent Diabetes Mellitus (NIDDM). Patient with ankle dorsiflexors stage 1 to 2 and ankle plantar flexors spasticity 1+ on. Patients willing to give informed consent and ready to follow simple instructions.
The exclusion criteria for the study are the patients having thrombolytic stroke with onset for > than six months, subjects with complications such as uncontrolled metabolic disorders and severe systemic disorders, e.g., renal or cardiac failure, altered sensorium, or coma. Those who are on tube feeding or intravenous fluid therapy. The patients of stroke with a history of trauma (Abhighatajanya), onset due to intracranial space-occupying lesions, post-surgical or postpartum complication, degenerative disorders of the brain or intracranial infectious disease or hemorrhagic nature. The patients with specific medical and psychological contraindications for electrical stimulation Brooks,4 patients with visual or auditory difficulties, anti-anxiolytic treatments. Pregnant women and lactating mothers will also excludedbe. Patients contraindicated for Vasti & Swedana therapy and patients with fixed ankle or foot contracture, pacemaker, and a metal plate in the lower limb will be excluded.
For group A, standard control modern treatment (Anti-thrombotic treatment, e.g. Tab. Ecosprin 75/150 mg OD and Tab. Notropril 800mg TDS) will be given along with physiotherapy. The physiotherapy sitting for motor relearning program and functional stimulation will be given for 55 mins per sitting, five days weekly for one month.
For group B, standard control modern treatment will be given along with Ayurveda Panchakarma and physiotherapy. In this case, gentle massage with Dashmoola Taila + Nadi Sweda with Dashmoola Qwath + medicated enema (alternate regime of Dashamoola Niruha Vasti with Anuvasana Vasti with Dashmoola Taila will be prescribed for the treatment. The alternative regime of medicated enema i.e., Anuvasana Vasti (oil enema) and Dashamoola Niruha Vasti (decoction enema) will be given on odd and even days respectively for one month, and physiotherapy for five days weekly for one month.
The methodology of the study is mentioned in Table 1 and the flowchart of the study design or methodology is given in Figure 1.
The assessment criteria will be the Fugl-Meyer assessment, one-leg stance test, gait parameters (distance and time parameters), modified Ashworth scale, functional reach test, quality of life scale, Barthel index, NIH stroke scale score (NIHSS)5,6
Improvements in the following assessment variables are expected as primary outcomes: Fugl-Meyer assessment for sensori-motor function of lower extremities, one-leg stance test, functional reach test for static and dynamic balance in patients, quality of life scale and Barthel index independent living of patients with Stroke, resistance experienced during passive range of motion based measured on Modified Ashworth scale NIHSS for improvements in clinical features of stroke are expected to be measured.7
• For physiotherapy (five days weekly for one month)
• Karma Vasti (alternate regime of Niruha Vasti with Dashmoola Qwath and Anuvasana Vasti with Dashamoola oil for complete one month, i.e., Day 1st–Day 30th)
Time schedule of enrolment: Patients with the first Stroke diagnosed with CT/MRI (thrombolytic Stroke only) without other neurological deficits but <6 months of onset will be enrolled for the study.
Interventions (including any run-ins and washouts): There are no washout periods; the intervention of Panchakarma treatment and Physiotherapy sitting for 30 days.
Assessments and visits for participants: Assessment will be carried out at baseline level and after the intervention, i.e., on the 30th day, then followup visits on the 60th and 90th day.
Patients will be recruited by simple randomization through the computer-generated table. The principal investigator (PI) and co-investigator (CO-I) will allocate and enroll the patient.
Using computer-generated random numbers, the researcher creates random allocation cards. He will keep the original random allocation sequences in a secure third location and work with an alternate copy. A researcher will enroll the patients.
The envelopes will be marked with serial numbers on the outside. The date, time, patient ID, post-procedure results, and other required details will be on the envelope.
For retention of patients, appointment reminders will be scheduled, and question-answering sessions will be planned. The complete followup will be mentioned in the patient file, and if patients are required to withdraw or discontinue, the patient file will be closed and maintained for the record purposes.
Observations will be made after the completion of the study, according to the data collected with the help of the following:
Data monitoring and coding will be done by the principal investigator and co-investigator. Data entry will be done in soft copy and case record form in hard copy. The values will be verified twice before submission in soft copy. Each file of the patient is secured with a specific patient code.
The data obtained will be calculated using the Student’s Paired ‘t-test and Unpaired ‘t’ test for objective variables with SPSS statistical software.
To verify the significance of the results
Improvements in Fugl-Meyer assessment-35%, one leg stance test-20%, functional reach test-35%, quality of life scale-25%, Barthel index-25% and NIH stroke-scale-score-20% will be considered as significant.
Cerebrovascular accidents (CVA) can be correlated with Pakshaghata in Ayurveda. Its pathophysiology evolves in Shira (head). In Ayurveda, Panchakarma is considered the most effective regime to break the pathogenesis of the disease from the root and avoid its recurrence. Snehana, Swedana, including Vasti, is the ultimate treatment modality for Pakshaghata. Acharya Sushruta stated that Vasti is half of the entire management of diseases having chronic and deeply rooted pathology, primarily for conditions originating from the morbid Vata Dosha.8,9 It is the most important as it drastically expels the vitiated Vata responsible for the movements of all Dosha, Dhatu, and Mala within the body. Niruha Vasti serves the purpose of the elimination of vitiated Vata Dosha. As Shosha of Sira and Snayu, which is the most critical event in the Samprapti of Pakshaghata, the Bruhana effect induced by Anuvasana Vasti, which pacifies Vata. Being an obstinate Vata disorder, Pakshaghata demands a pioneering treatment of Vata, i.e., Vasti, especially Shodhana or Bruhana Vasti, for a more extended period. Therefore, Vasti is considered one of the foremost treatments for Pakshaghata, capable of eliminating Doshas from the body.10,11 It sustains life by maintaining the harmony between Dosha, Dhatu, and Mala in the body.12,13
Among various types of Niruha Vasti Dravyas, Dashamula, i.e., a combination of the 10 drugs, is the best Tridoshahara, especially has Vatahara property; therefore, it is highly efficacious for Vata predominant disorders. Dashmoola Niruha Vasti & Anuvasana Vasti with Dashmoola Oil are considered very effective, providing additional benefits of Shodhana and Rasayana, which are expected in Pakshaghata.14–16
Due to this devastating and refractory nature of Pakshaghata, a minimum course of three months of appropriate treatment is recommended. Therefore, among detoxification procedures, Karma Vasti (course of 30 Vasti having a regime of alternate 18 Anuvasana Vasti and 12 Niruha Vasti) with Snehana and Swedana are selected for this study.17–20
Local Snehana and Swedana is the mandatory pre-procedural protocol before administering both Niruha and Anuvasana Vasti that is helpful to achieve expected proper procedural symptoms (i.e., Samyak Niruha and Anuvasana Vasti Lakshana). Moreover, it also increases the therapeutic outcome of these therapies by improving blood circulation in that local region.
As local massage nourishes the muscular tissue and fomentation with Dashmool decoction, massage quickly relieves the extremities’ stiffness, especially muscular tissues. Both these procedures also play an important role in enhancing the speed of rehabilitation of the stroke, resulting in a speedy recovery in cognitive functions hampered in it. According to Ayurveda, vitiation of Vata is the most important factor responsible for inducing impairment of cognitive functions and musculoskeletal movements. Both procedures were done by using Dashmoola oil and Dashmoola decoction, respectively, to pacify vitiated Vata due to their Snigdha & Ushna Guna. Moreover, both improve the gait of the patient & reduce the dependency of the affected individual on relatives.21,22 Local massage and fomentation with Vata pacifying medicines improve the patient’s quality of life by building confidence and contributing to induce expected positive outcomes.23
On the other hand, the efficacy of physiotherapy, especially of the “Motor Relearning Program” (MRP) and “Functional Electrical Stimulation” (FES) in the early rehabilitation of the stroke can be justified as follows:
Motor learning theory underpins the Motor Relearning Programme (MRP). Carr and Shepherd claimed that motor control training necessitates anticipatory acts as well as continuing exercise. The motor relearning program is useful for improving a group of post-stroke patients’ balance function and functional performance. It consists of four distinct steps, i.e., to analyze the task and practice the missing component and task with a transference of training. Eight studies suggested that MRP planned for five weeks showed better improvement in functional performance on self-care, instrumental activities of daily living, and integration into the community hospital.24
The FES is based on electrical stimulation to the peripheral nerves that innervate the paralyzed muscle to generate action potentials in motor neurons, propagating towards the power, and causing its contraction. According to John E.R. 1999 et al. and Niu et al., 2019, it is an excellent recovery tool for motor functions hampered in post-stroke conditions.
Both MRP and FES are quite useful to regain full mobility in such patients, enhance muscle strength and endurance, expand movement capacity, reduce atrophy, increase walking speed, reduce spasticity, and relieve pain. This technique is quite effective to improve the swing phase of the gait, correct a foot drop and decrease the energy expenditure during walking by restoring ankle dorsiflexion affected in the patient with stroke.25,26
In a nutshell, all-composite treatment modalities induce restoration of gross and fine movements, increase gait speed to the maximum extent quicker, decrease falls, and improve he patient’s quality of life.
Shreds of evidence generated from the current study may prove the positive benefits of the use of integrative approach of Dashamool Niruha Vasti in Panchakarma added with MRP and FES in physiotherapy, to improve gait and speed of movement, decrease the rate of fall while standing or walking, and improves quality of life of patients having stroke. This treatment protocol may become an effective tool in the rehabilitation of such patients, which may broaden the scope of Ayurveda in neurology.
Abhighatajanya – Trauma
Anuvasana Vasti – Oil enema
Bahya Snehana – Especially external oleation
Dashmool – Combination of 10 Ayurveda drugs
Dhatu – Body tissues
Dosha – Bio-humours
Karma Vasti – Alternate regime of decoction enema & medicated oil enema for complete one month
Kayachikitsa department – Medicine department
Mala – Body toxins
Niruha Vasti – Decoction enema
Niruha Vasti Dravyas – Decoction enema content
Pakshaghata – Paralysis
Panchakarma department – Purification Putative treatment department
Panchkarama – Purification putative treatment
Rasayana – Rejuvenation
Samprapti – Pathophysiology
Shira – Head
Shodhana – Purification
Snigdha Guna – Unctuousness quality
Swedana – Sudation therapy
Tridoshahara – Bio-humour enhancer
Ushna Guna – Hot quality
Vasti – Medicated Enema
Vata Dosha – Air entity in the body
Vatahara – Air entity pacifier
No data are associated with this article.
Figshare: SPIRIT checklist for ‘Efficacy of Dashmool Vasti as an adjuvant therapy with the standard of care (modern + physiotherapy) in the rehabilitation of stroke as compared to standard of care – a clinical trial protocol’. https://doi.org/10.6084/m9.figshare.24488059.
Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication).
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Panchakarma, Autoimmune diseases, Neurological diseases, Osteomuscular diseases, degenerative diseases, Stress and allergies
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 3 (revision) 10 Apr 24 |
read | |
Version 2 (revision) 15 Feb 24 |
read | read |
Version 1 14 Dec 23 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)